Clinical management and outcomes of HIV-positive patients newly diagnosed with prostate cancer: a single institution experience

Mark C. Markowski; Filip Pirsl; Jeanne C. Keruly; Geetanjali Chander; Richard D. Moore; Bryan Lau; Corinne E. Joshu

doi:10.1038/s41391-022-00586-7

Clinical management and outcomes of HIV-positive patients newly diagnosed with prostate cancer: a single institution experience

Mark C. Markowski, Filip Pirsl, Jeanne C. Keruly, Geetanjali Chander, Richard D. Moore, Bryan Lau, Corinne E. Joshu

Research output: Contribution to journal › Article › peer-review

Abstract

Introduction: 10-year outcomes in patients living with HIV who are diagnosed with prostate cancer are unknown. Methods: 52 patients living with HIV were diagnosed with prostate cancer. Disease-free survival stratified by clinical, pathologic, and HIV characteristics were examined. Results: No difference in disease-free survival was observed based on prostate cancer treatment modality, CD4 count, or HIV viral load. Conclusions: Prostate cancer outcomes in patients living with HIV are favorable irrespective of treatment modality.

Original language	English (US)
Pages (from-to)	144-146
Number of pages	3
Journal	Prostate Cancer and Prostatic Diseases
Volume	27
Issue number	1
DOIs	https://doi.org/10.1038/s41391-022-00586-7
State	Published - Mar 2024

ASJC Scopus subject areas

Oncology
Urology
Cancer Research

Access to Document

10.1038/s41391-022-00586-7

Cite this

@article{e4c6cdc717b944d793f1aaad864eeab6,

title = "Clinical management and outcomes of HIV-positive patients newly diagnosed with prostate cancer: a single institution experience",

abstract = "Introduction: 10-year outcomes in patients living with HIV who are diagnosed with prostate cancer are unknown. Methods: 52 patients living with HIV were diagnosed with prostate cancer. Disease-free survival stratified by clinical, pathologic, and HIV characteristics were examined. Results: No difference in disease-free survival was observed based on prostate cancer treatment modality, CD4 count, or HIV viral load. Conclusions: Prostate cancer outcomes in patients living with HIV are favorable irrespective of treatment modality.",

author = "Markowski, {Mark C.} and Filip Pirsl and Keruly, {Jeanne C.} and Geetanjali Chander and Moore, {Richard D.} and Bryan Lau and Joshu, {Corinne E.}",

note = "Publisher Copyright: {\textcopyright} The Author(s), under exclusive licence to Springer Nature Limited 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.",

year = "2024",

month = mar,

doi = "10.1038/s41391-022-00586-7",

language = "English (US)",

volume = "27",

pages = "144--146",

journal = "Prostate Cancer and Prostatic Diseases",

issn = "1365-7852",

publisher = "Springer Nature",

number = "1",

}

TY - JOUR

T1 - Clinical management and outcomes of HIV-positive patients newly diagnosed with prostate cancer

T2 - a single institution experience

AU - Markowski, Mark C.

AU - Pirsl, Filip

AU - Keruly, Jeanne C.

AU - Chander, Geetanjali

AU - Moore, Richard D.

AU - Lau, Bryan

AU - Joshu, Corinne E.

N1 - Publisher Copyright: © The Author(s), under exclusive licence to Springer Nature Limited 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

PY - 2024/3

Y1 - 2024/3

N2 - Introduction: 10-year outcomes in patients living with HIV who are diagnosed with prostate cancer are unknown. Methods: 52 patients living with HIV were diagnosed with prostate cancer. Disease-free survival stratified by clinical, pathologic, and HIV characteristics were examined. Results: No difference in disease-free survival was observed based on prostate cancer treatment modality, CD4 count, or HIV viral load. Conclusions: Prostate cancer outcomes in patients living with HIV are favorable irrespective of treatment modality.

AB - Introduction: 10-year outcomes in patients living with HIV who are diagnosed with prostate cancer are unknown. Methods: 52 patients living with HIV were diagnosed with prostate cancer. Disease-free survival stratified by clinical, pathologic, and HIV characteristics were examined. Results: No difference in disease-free survival was observed based on prostate cancer treatment modality, CD4 count, or HIV viral load. Conclusions: Prostate cancer outcomes in patients living with HIV are favorable irrespective of treatment modality.

UR - http://www.scopus.com/inward/record.url?scp=85137500485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85137500485&partnerID=8YFLogxK

U2 - 10.1038/s41391-022-00586-7

DO - 10.1038/s41391-022-00586-7

M3 - Article

C2 - 36057651

AN - SCOPUS:85137500485

SN - 1365-7852

VL - 27

SP - 144

EP - 146

JO - Prostate Cancer and Prostatic Diseases

JF - Prostate Cancer and Prostatic Diseases

IS - 1

ER -

Clinical management and outcomes of HIV-positive patients newly diagnosed with prostate cancer: a single institution experience

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this